US FDA approves Amgen drug for small cell lung cancer, Health News, ET HealthWorld
London: The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults...
London: The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults...
Many infants in the U.S. rely on infant formula for some or all of their nutrition. Ensuring that the youngest...